Show Summary Details
Page of

Disease-modifying therapies in advanced cancer 

Disease-modifying therapies in advanced cancer
Chapter:
Disease-modifying therapies in advanced cancer
Author(s):

Dirk Schrijvers

DOI:
10.1093/med/9780199656097.003.0122
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 07 May 2021

In many situations, anti-cancer therapies may be critical components of a palliative care plan to optimize patient comfort, function, quality of life, and duration of survival. Optimal care often requires the integration of oncological and palliative care and it is important for palliative care clinicians to be familiar with oncological approaches to improve patient well-being, and also the limitations of such approaches. This integrative role requires that palliative care clinicians have a basic literacy regarding anti-cancer therapies and that they be familiar with information resources to update them on new and developing therapeutic options which may be of benefit to their patients.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.